LAUSR

https://e-kcj.org Among the global burden of cardiovascular disease, 58% of cardiovascular mortality occurs in Asia and even it is increasing rapidly. Hypertension is the most common, powerful, and modifiable risk factor of the cardiovascular morbidity and mortality in the world. Much evidence supports that hypertension is the most effective risk factor for prevention of future cardiovascular events. Many healthcare policy makers and associated societies are trying to improve the hypertension control rate. But more than 50% of hypertensive patients do not get the target blood pressure (BP) and the control rates are static in recent 10 years. Lowering the diagnostic criteria of hypertension in American College of Cardiology/American Heart Association/American Society of Hypertension (ACC/AHA/ASH) and recommending initial fixed dose drug combination in European Society of Hypertension (ESH) are the mixture of pragmatic and scientific decision. The 2018 recommendation of Korean Society of Hypertension (KSH) is evidence-based but conservative guideline in improving control rate.1) The 2020 fact sheet of KSH revealed that the awareness, treatment and control rate of hypertension in young population deserve to pay attention and may be key to improve the control rate.